Optic neuritis: Clinical analysis of 27 cases

Kaohsiung Journal of Medical Sciences

Volumn 19, Issue 3, 2003, Pages 105-111

  Bee, Youn Shen ^a,b   Lin, Muh Chiou ^a   Wang, Cheng Chiang ^a   Sheu, Shwu Jiuan ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b Division of Neurosurgery   (Taiwan)

Author keywords

Chinese; Multiple sclerosis; Optic neuritis

Indexed keywords

ADOLESCENT; ADULT; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EVOKED VISUAL RESPONSE; EYE PAIN; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; PAPILLEDEMA; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; VISION; VISUAL FIELD;

EID: 0038707595     PISSN: 02575655     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1607-551x(09)70457-7     Document Type: Review

References (24)

1. Beck RW, Cleary PA, Trobe JD, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. N Engl J Med 1993;329:1746-69.
2. Perkin GD, Rose FC. Optic Neuritis and its Differential Diagnosis. New York: Oxford University Press, 1979.
3. Beck RW, Cleary PA, Anderson MM Jr, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 1992;326:581-8.
4. Barlow JS. Multiple sclerosis in North Korea and China. Neurology 1967;17:802.
5. Lin JC, Jou JR, Liaw SL, et al. Magnetic resonance imaging and computed tomography in optic neuritis. Acta Soc Ophthalmol Sin 1996;35:57-62.
6. Beck RW, Cleary PA, Backlund JC, et al. The Optic Neuritis Study Group. The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial. Ophthalmology 1994;101:1771-8.
7. Wakakura M, Mashimo K, Oono S, et al. Multicenter clinical trial for evaluating methylprednisolone pulse treatment of idiopathic optic neuritis in Japan. Jpn J Ophthalmol 1999;43:133-8.
8. Keltner JL, Johnson CA, Spurr JO, Beck RW. Baseline visual field profile of optic neuritis. The experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 1993;111:231-4.
9. Optic Neuritis Study Group. The clinical profile of optic neuritis: experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 1991;109:1673-8.
10. Wakakura M, Minei-Higa R, Oono S, et al. Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Jpn J Ophthalmol 1999;43:127-32.
11. Fang JP, Donahue SP, Lin RH. Global visual field involvement in acute unilateral optic neuritis. Am J Ophthalmol 1999;128: 554-65.
12. Frederiksen JL, Petrera J. Serial visual evoked potential in 90 untreated patients with acute optic neuritis. Surv Ophthalmol 1999;44(Suppl 1):S54-62.
13. Trauzettel-Klosinski S, Diener HC, Dietz K, Zrenner E. The effect of oral prednisolone on visual evoked potential latencies in acute optic neuritis monitored in a prospective, randomized, controlled study. Doc Ophthalmol 1996;91:165-79.
14. Slamovits TL, Beck RW, Frenkel M. What to tell the patient with optic neuritis about multiple sclerosis. Surv Ophthalmol 1991;36:47-50.
15. Optic Neuritis Study Group. The 5-year risk of MS after optic neuritis. Experience of the Optic Neuritis Treatment Trial. Neurology 1997;49:1404-13.
16. Rodriguez M, Siva A, Cross SA, et al. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 1995;45:244-50.
17. Francis DA, Compston DAS, Batchelor JR, McDonald WI. A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. J Neurol Neurosurg Psychiatry 1987;50:758-65.
18. Frith JA, McLeod JG, Hely M. Acute optic neuritis in Australia: a 13 year prospective study. J Neurol Neurosurg Psychiatry 2000;68:246-51.
19. Sandberg-Wollheim M, Bynke H, Cronqvist S, et al. A longterm prospective study of optic neuritis: evaluation of risk factors. Ann Neurol 1990;27:386-93.
20. Alter M, Good J, Okihiro M. Optic neuritis in Orientals and Caucasians. Neurology 1973;23:631-9.
21. Trobe JD. High-dose corticosteroid regimen retards development of multiple sclerosis in Optic Neuritis Treatment Trial. Arch Ophthalmol 1994;112:35-6.
22. Beck RW, Kupersmith MJ, Gleary PA, Katz B. Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group. Ophthalmology 1993;100:691-7.
23. Beck RW, Cleary PA. Optic Neuritis Treatment Trial. One-year follow-up results. Arch Ophthalmol 1993;111:773-5.
24. Chrousos GA, Kattah JC, Beck RW, et al: Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial. JAMA 1993;269:2110-2.